U01CA250040
Cooperative Agreement
Overview
Grant Description
Exploiting the mechanobiology of PD-1 for cancer immunotherapy.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Atlanta,
Georgia
303320420
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 438% from $656,845 to $3,532,601.
Georgia Tech Research was awarded
Exploiting the Mechanobiology of PD-1 for Cancer Immunotherapy
Cooperative Agreement U01CA250040
worth $3,532,601
from National Cancer Institute in June 2020 with work to be completed primarily in Atlanta Georgia United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.396 Cancer Biology Research.
The Cooperative Agreement was awarded through grant opportunity Physical Sciences-Oncology Network (PS-ON): Physical Sciences-Oncology Projects (PS-OP) (U01 Clinical Trial Optional).
Status
(Complete)
Last Modified 7/19/24
Period of Performance
6/1/20
Start Date
5/31/25
End Date
Funding Split
$3.5M
Federal Obligation
$0.0
Non-Federal Obligation
$3.5M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for U01CA250040
Transaction History
Modifications to U01CA250040
Additional Detail
Award ID FAIN
U01CA250040
SAI Number
U01CA250040-1024968654
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Funding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Awardee UEI
EMW9FC8J3HN4
Awardee CAGE
1G474
Performance District
GA-05
Senators
Jon Ossoff
Raphael Warnock
Raphael Warnock
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
National Cancer Institute, National Institutes of Health, Health and Human Services (075-0849) | Health research and training | Grants, subsidies, and contributions (41.0) | $2,134,942 | 100% |
Modified: 7/19/24